Journal of Antivirals & Antiretrovirals : Citations & Metrics Report
Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.
Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
59 | 57 | 32 | 59 | 77 | 13 | 11 | 20 | 37 | 22 | 37 | 55 | 22 | 12 |
Research, Review articles and Editorials |
1 | 0 | 5 | 42 | 32 | 12 | 10 | 14 | 27 | 21 | 33 | 44 | 21 | 10 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
48 | 57 | 27 | 17 | 45 | 1 | 1 | 6 | 10 | 1 | 4 | 11 | 1 | 2 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 35 | 51 | 125 | 100 | 191 | 0 | 125 | 177 |
Citations received as per Google Scholar, other indexing platforms and portals |
98 | 160 | 172 | 269 | 223 | 172 | 219 | 195 | 170 | 116 | 60 | 36 | 26 | 58 |
Journal total citations count | 2004 |
Journal impact factor | 5.32 |
Journal 5 years impact factor | 5.62 |
Journal cite score | 5.3 |
Journal h-index | 22 |
Journal h-index since 2019 | 17 |
Important citations (1101)
Unlocking the health potential of microalgae as sustainable sources of bioactive compounds |
|
The potential of algal biotechnology to produce antiviral compounds and biopharmaceuticals |
|
Strategies to obtain designer polymers based on cyanobacterial extracellular polymeric substances (eps) |
|
Protective effect of 3-bromo-4,5-dihydroxybenzaldehyde from polysiphonia morrowii harvey against hydrogen peroxide-induced oxidative stress in vitro and in vivo |
|
Chapter eleven - algal and microbial exopolysaccharides: new insights as biosurfactants and bioemulsifiers |
|
Marine algal carbohydrates as carbon sources for the production of biochemicals and biomaterials |
|
Influence of sulphate on the composition and antibacterial and antiviral properties of the exopolysaccharide from porphyridium cruentum |
|
Performance characteristics of finger-stick dried blood spots (dbs) on the determination of human immunodeficiency virus (hiv) treatment failure in a pediatric population in mozambique |
|
Uptake of routine viral load testing among people living with hiv and its implementation challenges in yangon region of myanmar: a mixedmethods study |
|
The performance of a new point-of-care hiv virus load technology to identify patients failing antiretroviral treatment |
|
Immunoinformatics and molecular modeling approach to design universal multi-epitope vaccine for sars-cov-2 |
|
Subtractive proteomics to identify targets for vaccine development against vancomycin-resistant enterococcus faecalis |
|
Identification of therapeutic drug target of stenotrophomonas maltophilia through subtractive genomic approach and in-silico screening based on 2d similarity filtration and molecular dynamic simulation |
|
Subtractive genomic analysis for identification of novel drug targets and vaccine candidates against bartonella bacilliformis subsp. ver097 |
|
Emerging antibiotic resistance in mycoplasma microorganisms, designing effective and novel drugs / therapeutic targets: current knowledge and futuristic prospects |
|
An immunopharmacoinformatics approach in development of vaccine and drug candidates for west nile virus |
|
Emerging antibiotic resistance in mycoplasma microorganisms, designing effective and novel drugs / therapeutic targets: current knowledge and futuristic prospects |
|
Potential drug target identification of legionella pneumophila by subtractive genome analysis: an in silico approach |
|
Prevalence of intestinal parasitic protozoan infections among female hiv/aids patients attending aminu kano teaching hospital, kano, kano state, nigeria |
|
Modeling novel putative drugs and vaccine candidates against tick-borne pathogens: a subtractive proteomics approach |
|